Some directors and senior executives of Zhejiang Haisen Pharmaceutical (001367.SZ) plan to reduce their holdings by a total of no more than 124,300 shares.

Zhejiang Haisen Pharmaceutical (001367.SZ) announced that some directors and senior management of the company plan to collectively reduce their holdings of the company's shares by a total of 12.43 million shares (0.0816% of the total share capital) through centralized competitive trading within 3 months after 15 trading days from the date of this announcement, from December 26, 2025 to March 25, 2026.